# Effects of Botox in Obstructed Defecation Syndrome

> **NCT02160288** · PHASE2 · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 1 (actual)

## Conditions studied

- Obstructed Defecation Syndrome (ODS)

## Interventions

- **DRUG:** Botulinum Toxin-A
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT02160288
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-02
- **Primary completion:** 2019-06-11
- **Final completion:** 2019-06-11
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Low recruitment
- **Last updated:** 2020-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02160288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02160288, "Effects of Botox in Obstructed Defecation Syndrome". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02160288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*